In the present work, which combines both in silico, in vitro and in vivo approaches, we validated the clinical impact of BGN expression in GC patient samples, and we have established unique GC cellular models to study the effect of mature biglycan in GC aggressiveness. Here, BGN is linked to gastric cancer.